Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume 56, Issue 1, Pages 7-16
Publisher
Informa UK Limited
Online
2016-12-25
DOI
10.1080/0284186x.2016.1253861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic review and meta-analysis of the prognostic value of total cell-free DNA quantification in metastatic colorectal cancer
- (2016) K.-L.G. Spindler et al. ANNALS OF ONCOLOGY
- Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma
- (2016) Dina El-Gayar et al. Asian Pacific Journal of Cancer Prevention
- Characterization of the cell-free DNA released by cultured cancer cells
- (2016) Abel Jacobus Bronkhorst et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis
- (2016) Guanghua Li et al. BMC CANCER
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
- (2016) Matthew W. Snyder et al. CELL
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Controls to validate plasma samples for cell free DNA quantification
- (2015) Niels Pallisgaard et al. CLINICA CHIMICA ACTA
- Cell-free DNA: Preanalytical variables
- (2015) Abel Jacobus Bronkhorst et al. CLINICA CHIMICA ACTA
- Improved sensitivity of circulating tumor DNA measurement using short PCR amplicons
- (2015) Rikke Fredslund Andersen et al. CLINICA CHIMICA ACTA
- EDTA-mediated inhibition of DNases protects circulating cell-free DNA from ex vivo degradation in blood samples
- (2015) Gustavo Barcelos Barra et al. CLINICAL BIOCHEMISTRY
- Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
- (2015) J. S. Frenel et al. CLINICAL CANCER RESEARCH
- Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer
- (2015) David Sefrioui et al. DIGESTIVE AND LIVER DISEASE
- Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy
- (2015) Karen-Lise Garm Spindler et al. EUROPEAN JOURNAL OF CANCER
- Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
- (2015) Andrea Wong et al. Journal of Translational Medicine
- Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
- (2015) Evelyn Kidess et al. Oncotarget
- Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
- (2015) Filip Janku et al. Oncotarget
- Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review
- (2015) Benoist Chibaudel et al. Therapeutic Advances in Medical Oncology
- Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
- (2015) Karen Lise Garm Spindler et al. PLoS One
- Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
- (2014) Alison S. Devonshire et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
- (2014) T B Hao et al. BRITISH JOURNAL OF CANCER
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA,KRASandBRAFin the plasma
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
- (2014) Jian-Ming Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
- (2014) Ronald Lebofsky et al. Molecular Oncology
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
- (2014) Sumitra Mohan et al. PLoS Genetics
- Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma
- (2013) Karen-Lise G. Spindler et al. ACTA ONCOLOGICA
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
- (2013) K G Spindler et al. BRITISH JOURNAL OF CANCER
- Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer
- (2013) S.H. Lim et al. CANCER LETTERS
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
- (2013) V. Taly et al. CLINICAL CHEMISTRY
- Circulating cell-free DNA in serum as a biomarker of colorectal cancer
- (2013) Benisio Ferreira da Silva Filho et al. JOURNAL OF CLINICAL PATHOLOGY
- Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
- (2012) L. Benesova et al. ANALYTICAL BIOCHEMISTRY
- Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
- (2012) A. Narayan et al. CANCER RESEARCH
- Alu-based cell-free DNA: A potential complementary biomarker for diagnosis of colorectal cancer
- (2012) Jing Qi et al. CLINICAL BIOCHEMISTRY
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients
- (2012) Florent Mouliere et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine
- (2012) Elizabeth Day et al. METHODS
- Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
- (2012) Geraldine Perkins et al. PLoS One
- Measurement of Circulating Cell-Free DNA Levels by a New Simple Fluorescent Test in Patients With Primary Colorectal Cancer
- (2011) David Czeiger et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- Methods for isolation of cell-free plasma DNA strongly affect DNA yield
- (2011) Michael Fleischhacker et al. CLINICA CHIMICA ACTA
- Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
- (2011) Leticia De Mattos-Arruda et al. Future Oncology
- Quantitative and sensitive detection of rare mutations using droplet-based microfluidics
- (2011) Deniz Pekin et al. LAB ON A CHIP
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers
- (2010) Elisa Danese et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
- (2010) Li-Xin Qiu et al. EUROPEAN JOURNAL OF CANCER
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- Detection of Mutated K-rasDNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
- (2009) Ying-Hsiu Su et al. Annals of the New York Academy of Sciences
- Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
- (2009) Maniesh van der Vaart et al. CLINICAL BIOCHEMISTRY
- Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2009) L.-C. Yen et al. CLINICAL CANCER RESEARCH
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
- (2008) M. Frattini et al. CANCER LETTERS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Cell-free DNA resuscitated for tumor testing
- (2008) Michael Fleischhacker et al. NATURE MEDICINE
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations
- (2008) Héctor Guadalajara et al. Cancer Detection and Prevention
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started